To learn more about the multifaceted effects of the COVID-19 pandemic on people living with HIV and how clinicians can best support these patients, we interviewed experts who have co-authored recently published papers pertaining to this topic.
By providing bundled HIV and HCV testing, substance use disorder treatment programs may create increased awareness of infection status among people with substance abuse disorders.
Excess mortality occurred as the result of a number of causes, including overdose, injuries, and both infectious and noncommunicable diseases.
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
Social adversity may increase rates of psychotropic prescriptions, which have surged in recent decades, prompting researchers to perform a study of food insecurity and psychotropic prescriptions among women living with HIV.
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Hepatitis B virus prevalence was 7 to 10 times higher in a homeless population of Los Angeles compared to the general population of the United States.
Few current treatments currently target PTSD and substance use disorder at the same time.
A new intervention successfully reduced the amount of HIV risk behavior in the community of Hispanic/Latino men who have sex with men.
Depression and coping mechanisms play a role in the sexual behavior of teenage heterosexual black adolescents.
